Location History:
- Tucson, AZ (US) (2018)
- Durham, NC (US) (2020)
Company Filing History:
Years Active: 2018-2020
Title: Edwin Paz: Innovator in Cancer Therapy
Introduction
Edwin Paz is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 2 patents, his work focuses on improving therapeutic methods for cancer treatment.
Latest Patents
Paz's latest patents include groundbreaking methods related to predictive markers for polyamine inhibitor cancer therapies. The first patent discusses therapeutic methods that involve identifying cancer marker surrogates for increased polyamine expression. These markers are crucial for identifying patients who may benefit from treatments using polyamine synthesis inhibitors. Additionally, they can be utilized to monitor therapeutic responses when such agents are administered. The second patent reiterates similar findings, emphasizing the correlation between reduced levels of let-7 miRNA and elevated levels of LIN28 and HMGA2 proteins with increased polyamine levels. This discovery is vital for predicting the efficacy of cancer therapies that utilize ornithine decarboxylase (ODC1) inhibitors, such as eflornithine (DFMO), particularly when combined with NSAIDs like sulindac.
Career Highlights
Edwin Paz is affiliated with the University of Arizona, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.
Collaborations
Paz collaborates with esteemed colleagues, including Eugene W Gerner and Bonnie LaFleur, who contribute to his research endeavors.
Conclusion
Edwin Paz's innovative work in cancer therapy showcases his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of cancer treatment and the potential for improved therapeutic strategies.